A
David Kessler, who led the FDA for more than six years starting in 1990, took the stand at a trial in Houston on Wednesday as a paid expert witness for opponents of J&J’s $9 billion settlement plan to end cancer cases targeting its signature powder.
Kessler said his review of evidence emerging from more than 15 years of litigation after ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.